Search - tctmd.com

Displaying 401 - 420 of 676

Sort: Relevancy | Date

Presentation TVT 2019

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Presenter: Karim Al-Azizi

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve Replacement With the ACURATE Neo2 Valve System: 1-Year Clinical and Hemodynamic Outcomes

Presenter: Helge Möllmann

June 13, 2019

Presentation TVT 2019

Secondary Curve on TAVR Delivery Wire Effects on Outcomes in Patients With Severe Aortic Root Angles

Presenter: Philip Carson

June 13, 2019

Presentation TVT 2019

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Presenter: Axel Linke

June 13, 2019

Presentation TVT 2019

Pachyderm-Shape Guiding Catheters to Simplify BASILICA Leaflet Traversal

Presenter: John Lisko

June 13, 2019

Presentation TVT 2019

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

Presenter: Bhaskar Bhardwaj

June 13, 2019

Presentation TVT 2019

OPTIMUM TAV First-In-Human Results

Presenter: Mathew Williams

June 13, 2019

Presentation TVT 2019

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Presenter: Fabiula Azevedo

June 13, 2019

Presentation TVT 2019

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Presenter: Gilbert Tang

June 13, 2019

Presentation TVT 2019

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Presenter: Rashad Belin

June 13, 2019

Presentation TVT 2019

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

Presenter: Sarah Gualano

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Systematic — In All Patients, Whenever Possible!

Presenter: Nicolas Van Mieghem

June 13, 2019

Presentation TVT 2019

Selective Use — Is There a Middle Ground?

Presenter: Jeffrey Moses

June 13, 2019

Presentation TVT 2019

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Presenter: Hemal Gada

June 13, 2019

Presentation TVT 2019

Not Necessary — Soft Data and Excessive Costs!

Presenter: David Muller

June 13, 2019

Presentation TVT 2019

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Presenter: Julia Seeger

June 13, 2019

Presentation TVT 2019

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

Presenter: Tamim Nazif

June 13, 2019

Presentation TVT 2019

The PARTNER 3 Low-Risk Randomized Trial

Presenter: Susheel Kodali

June 13, 2019

Advertisement

Transcatheter Aortic Valve-in-Valve in Patients With Previous Homograft

Transcatheter Aortic Valve Replacement With the ACURATE Neo2 Valve System: 1-Year Clinical and Hemodynamic Outcomes

Secondary Curve on TAVR Delivery Wire Effects on Outcomes in Patients With Severe Aortic Root Angles

Safety, Feasibility, and Acute Performance of the Leaflex™ Performer When Used Pre-TAVI in Aortic Stenosis Patients (The Leaflex™ Performer Feasibility Study)

Pachyderm-Shape Guiding Catheters to Simplify BASILICA Leaflet Traversal

Outcomes of Transcatheter Aortic Valve Replacement (TAVR) for Mixed Aortic Valve Disease: Results From the TVT Registry

OPTIMUM TAV First-In-Human Results

Occurrence of Left Ventricular Reverse Remodeling After Transcatheter Aortic Valve Replacement: Analysis of a Brazilian Cohort

Initial Experience With the JenaValve Transfemoral TAVR System in Patients With Severe Aortic Stenosis and Risk for Coronary Occlusion

Feasibility of Repeat Transcatheter Aortic Valve Replacement (TAVR) After Sapien 3 TAVR (TAV-in-TAV): A Pilot Angiographic Study

Diabetes Mellitus: Is There a True Paradoxical Clinical Outcome After AVR?

Acute Kidney Injury After Transcatheter Aortic Valve Replacement Is a Strong Predictor of Intermediate but Not Long-Term Mortality: Observations From Michigan Transcatheter Aortic Valve Replacement (MITAVR) Registry

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Systematic — In All Patients, Whenever Possible!

Selective Use — Is There a Middle Ground?

Rationalizing the Cost Effectiveness of Cerebral Protection During TAVR

Not Necessary — Soft Data and Excessive Costs!

Comprehensive Review of the Sentinel Cerebral Embolic Protection Program

Cerebral Embolic Protection for TAVR With TriGuard 3: Updates From the REFLECT Clinical Trial

The PARTNER 3 Low-Risk Randomized Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content